TEST PARAMETERS INCLUDED ON THE FINAL REPORT:

Every formal Second Trimester Triple Marker report is structured across core analytical, sonographic, and statistical parameters:

• Alpha-Fetoprotein (AFP): Raw serum concentration reported in \text{IU/mL} or \text{ng/mL}.
• AFP MoM (Multiple of the Median): Normalized value adjusted for exact gestational age, weight, ethnicity, and maternal factors.
• Total Human Chorionic Gonadotropin (Total hCG): Raw serum concentration reported in \text{IU/mL} or \text{mIU/mL}.
• Total hCG MoM (Multiple of the Median): Normalized value adjusted for gestational age and maternal demographics.
• Unconjugated Estriol (uE3): Raw serum concentration reported in \text{ng/mL} or \text{nmol/L}.
• uE3 MoM (Multiple of the Median): Normalized value reflecting feto-placental steroid unit activity.
• Ultrasound Dating Parameters: Biparietal Diameter (BPD) or Femur Length (FL) in millimeters (\text{mm}) confirming exact gestational weeks and days.
• Age-Only Background Risk: Base statistical risk calculated solely from maternal age at estimated date of delivery (EDD).
• Calculated Risk for Trisomy 21 (Down Syndrome): Overall personalized risk ratio synthesizing biochemistry and age inputs (e.g., 1:3200).
• Calculated Risk for Trisomy 18 (Edwards Syndrome): Overall personalized combined risk ratio.
• Neural Tube Defect (ONTD) Risk Status: Risk assessment based on maternal serum AFP MoM (typically elevated if \text{AFP} \ge 2.0\text{ to } 2.5\text{ MoM}).
• Pathologist & Genetic Screening Specialist Remarks: Clinical summary explaining risk categorization (Screen Negative vs. Screen Positive) and recommending next diagnostic steps.

MARKERS

METHODOLOGY & RISK CALCULATION ENGINE: * Analytical Platform: Time-Resolved Immunofluorometry (AutoDELFIA by Revvity). AutoDELFIA utilizes lanthanide chelate fluorescence (Europium/Samarium tracers) with a time-delayed fluorescence measurement window, eliminating natural biological background autofluorescence and delivering high sensitivity and precision across low maternal serum concentrations. * Risk Engine: LifeCycle 7.0 Software (Version 6.0, Revvity). The software uses multi-parametric Gaussian distribution algorithms to compare the patient's individual biomarker MoMs against established population medians, calculating precise, adjusted likelihood ratios.

SERUM 3ML

CRITICAL PREPARATION & SPECIMEN LOGISTICS: * No Fasting Required: Strict fasting is not mandatory. Routine maternal meals and hydration do not alter circulating AFP, hCG, or uE3 levels. * Mandatory Dating Ultrasound Scan: A certified second-trimester ultrasound scan (performed at 15.0 to 20.6 weeks) must be available. The ultrasound report must clearly specify: * Biparietal Diameter (BPD) or Crown-Rump Length / Femur Length. * Exact sonographic gestational age. * Number of fetuses (Singleton vs. Twin gestation). * Mandatory Maternal Requisition Form Details: Accurate entry of maternal date of birth, exact weight (\text{kg}), diabetic status (insulin-dependent diabetes lowers AFP), smoking history, method of conception (Natural vs. IVF with ovum donor age), and prior pregnancy history with neural tube defects or chromosomal aneuploidies. * Sample Required: Requires a standard venous blood draw yielding Serum (3 mL minimum) collected in a standard red-top or gold-top gel-barrier clot activator tube.

Why does the Triple Marker Advance AutoDELFIA test report require a 24 to 36-hour turnaround window?

Delivering precise quantitative results for prenatal risk calculation involves multi-stage processing. This includes serum separation, running automated time-resolved immunofluorometric assays for AFP, Total hCG, and uE3 on the AutoDELFIA analyzer, calibrating fluorescence standard curves, converting raw concentrations into Multiples of the Median (MoMs), entering patient and ultrasound variables into LifeCycle 7.0 software, computing statistical risks, and final review by our pathology and genetic screening team.

What is the primary purpose of the Triple Marker test during pregnancy?

The Triple Marker test is a second-trimester maternal screening test that evaluates the statistical likelihood that a baby may have Down Syndrome (Trisomy 21), Edwards Syndrome (Trisomy 18), or Open Neural Tube Defects (such as Spina Bifida or Anencephaly).

Why is this test strictly performed between 15.0 and 20.6 weeks of gestation?

The biochemical relationship between AFP, hCG, and uE3 in normal pregnancies versus those affected by chromosomal or neural tube defects is established and reliable during this gestational window (ideally between 16 and 18 weeks). Testing outside this window invalidates the standardized population medians used for risk calculation.

What is \"AutoDELFIA,\" and why is it considered the gold standard for prenatal screening?

AutoDELFIA (Automated Dissociation-Enhanced Lanthanide Fluorescent Immunoassay) utilizes time-delayed fluorescence with Europium tracers. Because it measures light emission only after natural background fluorescence has decayed, it provides higher analytical sensitivity, precision, and reproducibility compared to standard ELISA or basic chemiluminescence assays.

What does \"MoM\" (Multiple of the Median) mean on my report?

Because hormone concentrations naturally change with each day of pregnancy and vary with maternal weight, raw values cannot be compared directly. The raw laboratory value is divided by the median value for a healthy pregnancy at that exact gestational day and weight, yielding a standardized Multiple of the Median (MoM). A MoM of 1.0 represents the exact population average.

What is an Open Neural Tube Defect (ONTD), and how does the test detect it?

Neural tube defects occur when the fetal spine or skull does not close completely during early development (e.g., Spina Bifida or Anencephaly). When an opening exists, fetal Alpha-Fetoprotein (AFP) leaks into the amniotic fluid and crosses into maternal blood, resulting in significantly elevated maternal serum AFP levels (≥ 2.0\text{ to } 2.5\text{ MoM}).

What does a \"High Risk\" or \"Screen Positive\" result for Down Syndrome mean?

A \"Screen Positive\" result does not mean the baby has Down Syndrome; it means the statistical probability is higher than the established cut-off (e.g., 1\text{ in } 120 instead of 1\text{ in } 1000). It indicates that further evaluation—such as a targeted Level-II ultrasound, NIPT, or confirmatory amniocentesis—is recommended.

What does a \"Low Risk\" or \"Screen Negative\" result mean?

A \"Screen Negative\" result means the probability of the baby having Down Syndrome, Edwards Syndrome, or an open neural tube defect is low. While it provides substantial reassurance, no screening test can completely rule out all birth defects.

Why is an accurate ultrasound gestational age required for this test?

Biochemical marker levels change significantly week by week in the second trimester. If the estimated gestational age is off by even one or two weeks (due to irregular periods), the calculated MoM values will be inaccurate, potentially causing a false-positive or false-negative result. Using ultrasound measurements (such as BPD) ensures precise gestational dating.

Do I need to fast before providing a blood sample for the Triple Marker test?

No. Fasting is entirely unnecessary. Routine meals and water intake do not alter circulating AFP, hCG, or uE3 levels, allowing you to have your blood drawn at any convenient time during the 15.0 to 20.6-week window.

Can twin pregnancies be screened using the Triple Marker test?

Yes, but interpretation requires specialized adjustment. Twin pregnancies produce higher baseline amounts of AFP and hCG because there are two fetuses and two placentas. The LifeCycle software applies validated correction factors for twin gestations.

What is the difference between the Dual Marker test and the Triple Marker test?

The Dual Marker test is performed in the first trimester (11.0–13.6 weeks) using Free \beta-hCG and PAPP-A combined with an NT ultrasound. The Triple Marker test is performed in the second trimester (15.0–20.6 weeks) using AFP, Total hCG, and uE3. It is ideal for patients who missed the first-trimester window or who need screening for neural tube defects.

What is the difference between a screening test and a diagnostic test?

A screening test (like the Triple Marker test or NIPT) estimates the statistical probability of a condition without posing any physical risk to the pregnancy. A diagnostic test (like Amniocentesis) examines actual fetal cells to provide a definitive, confirmed diagnosis.

What does an elevated AFP level mean if the fetal spine and brain are normal on ultrasound?

If a high-resolution ultrasound confirms a completely normal fetal spine and skull, an elevated AFP can sometimes be associated with placental variations, minor placental bleeding, abdominal wall defects, or pregnancy-induced hypertension later in pregnancy.

How does maternal body weight affect the test results?

Mothers with higher body weight have a larger total blood volume, which naturally dilutes circulating biochemical markers. The LifeCycle software adjusts for maternal weight so that marker concentrations are accurately interpreted.

Is this maternal blood draw safe for the baby?

Yes, completely safe. It requires a routine, non-invasive venous blood collection (3 mL) from the mother's arm, carrying zero physical risk to the pregnancy or the developing baby.

What is Edwards Syndrome (Trisomy 18)?

Edwards Syndrome is a chromosomal condition caused by an extra copy of chromosome 18, leading to multiple structural organ anomalies and developmental delays. On the Triple Marker test, it characteristically presents with very low levels across all three markers (low AFP, low hCG, and low uE3).

What is the standard immediate medical approach if my Triple Marker test returns high risk?

A high-risk result indicates a clear next step. Your obstetrician will review the ultrasound dating, perform or refer for a detailed Level-II anomaly scan (TIFFA), and discuss follow-up options, which may include genetic counseling, NIPT, or confirmatory Amniocentesis.

How can our family securely access and download our final digital PDF report file?

As soon as the AutoDELFIA run and LifeCycle risk calculations are verified and signed off by our consultant pathology team, your secure digital report can be downloaded from www.drpatholab.in using your registered credentials.

Are my personal prenatal records, genetic profiles, and laboratory data kept private?

Absolute adherence to medical privacy standards, sample identity logging protocols, and encrypted data channels across our digital infrastructure guarantees that your entire diagnostic and prenatal profile remains strictly confidential and secure.